Literature DB >> 21850985

Anaplastic large-cell lymphoma.

Giorgio Inghirami1, Stefano A Pileri.   

Abstract

The concept of anaplastic large-cell lymphoma (ALCL) has changed over the years because of a stream of new information and novel understanding regarding the cell of origin, biology, genetics, and clinical features of these neoplasms. This new information has led to the current classification proposed by the expert reviewers of the World Health Organization. The objective of this review is to present the most updated information on the cytologic and histologic features of these entities, with a special reference to diagnostic algorithms. A detailed description of the genetic aberrations and the pathogenetic mechanisms leading to transformation is presented. The clinical features of ALCL and novel tailored strategies are briefly illustrated.

Entities:  

Mesh:

Year:  2011        PMID: 21850985     DOI: 10.1053/j.semdp.2011.03.002

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  14 in total

1.  Novel therapies for peripheral T-cell lymphomas.

Authors:  Andrei Shustov
Journal:  Ther Adv Hematol       Date:  2013-06

2.  Anaplastic large cell lymphoma involving anterior segment of the eye.

Authors:  Choul Yong Park; Sang Won Hwang; Do Yeun Kim; Hee Jin Huh; Jong-Hyun Oh
Journal:  Korean J Ophthalmol       Date:  2014-01-21

Review 3.  Molecular genetics of peripheral T-cell lymphomas.

Authors:  Pier Paolo Piccaluga; Valentina Tabanelli; Stefano A Pileri
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

4.  Cleavage of the JunB transcription factor by caspases generates a carboxyl-terminal fragment that inhibits activator protein-1 transcriptional activity.

Authors:  Jason K H Lee; Joel D Pearson; Brandon E Maser; Robert J Ingham
Journal:  J Biol Chem       Date:  2013-06-09       Impact factor: 5.157

5.  The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell lines.

Authors:  S Carnesecchi; A-L Rougemont; J H Doroshow; M Nagy; S Mouche; F Gumy-Pause; I Szanto
Journal:  Free Radic Biol Med       Date:  2015-03-19       Impact factor: 7.376

Review 6.  Genetic Landscape and Classification of Peripheral T Cell Lymphomas.

Authors:  Rosalind F Sandell; Rebecca L Boddicker; Andrew L Feldman
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

7.  The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update.

Authors:  Raymond Lai; Robert J Ingham
Journal:  Ther Adv Hematol       Date:  2013-04

Review 8.  Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma.

Authors:  Fabrizio Tabbò; Maurilio Ponzoni; Raul Rabadan; Francesco Bertoni; Giorgio Inghirami
Journal:  Curr Opin Hematol       Date:  2013-07       Impact factor: 3.284

9.  CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.

Authors:  Shimin Hu; Zijun Y Xu-Monette; Aarthi Balasubramanyam; Ganiraju C Manyam; Carlo Visco; Alexander Tzankov; Wei-min Liu; Roberto N Miranda; Li Zhang; Santiago Montes-Moreno; Karen Dybkær; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Qin Huang; Jooryung Huh; Weiyun Ai; Maurilio Ponzoni; Andrés J M Ferreri; Xiaoying Zhao; Jane N Winter; Mingzhi Zhang; Ling Li; Michael B Møller; Miguel A Piris; Yong Li; Ronald S Go; Lin Wu; L Jeffrey Medeiros; Ken H Young
Journal:  Blood       Date:  2013-01-23       Impact factor: 22.113

10.  Gingival Anaplastic Large-Cell Lymphoma Mimicking Hyperplastic Benignancy as the First Clinical Manifestation of AIDS: A Case Report and Review of the Literature.

Authors:  Rafaela Elvira Rozza-de-Menezes; Stefânia Jeronimo Ferreira; Diogo Lenzi Capella; Stephan Schwartz; Ana Helena Willrich; Lúcia de Noronha; Aline Cristina Batista Rodrigues Johann; Paulo Henrique Couto Souza
Journal:  Case Rep Dent       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.